NEUE
NeueHealth Inc
NeueHealth Inc historical holders
total: 1
Tiger Global Management NeueHealth Inc transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2021 Q2
- Held for:
- 3 quarters
- Latest activity:
- 2022 Q1
Chase Coleman III has been an institutional investor in NeueHealth Inc (NEUE) since 2021 Q2. According to 2026 Q1 report, Chase Coleman III doesn't hold any shares. The fund/company first acquired NEUE in 2021 Q2, initially purchasing 148,098 shares. Since the initial investment, Tiger Global Management has made 2 more transactions in this position.
When did Chase Coleman III exit their NEUE position?
Chase Coleman III no longer holds NeueHealth Inc (NEUE). They sold off their entire position in 2022 Q1, closing out an investment that began in 2021 Q2.
When did Chase Coleman III first invest in NEUE?
Chase Coleman III first invested in NeueHealth Inc (NEUE) in 2021 Q2 at the reported quarter-end price of $1,372.80 per share, acquiring 148,098 shares in their initial purchase.
What is Chase Coleman III's average cost basis for NEUE?
Based on historical transaction data, Chase Coleman III's estimated cost basis for NeueHealth Inc (NEUE) is approximately $1,372.80 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $1,372.80
- Weighted AVG sell price:
- $275.20
NEUE transactions history by Tiger Global Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$275.20
|
|
-100% (-41,875)
|
-0.03%
|
|
2021 Q4
|
0.03%
|
41,875
|
$275.20
|
$11,524,000
|
-71.72% (-106,222.6)
|
-0.06%
|
|
2021 Q2
|
0.38%
|
148,097.6
|
$1,372.80
|
$203,308,000
|
new
|
+0.38%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.